益肾疏肝止泻方加减联合帕罗西汀治疗早泄肝郁肾虚证临床研究OA
Clinical study on the efficacy of modified Yishen Shugan Zhixie formula combined with paroxetine in treating premature ejaculation with liver qi stagnation and kidney deficiency syndrome
目的:探索益肾疏肝止泻方加减联合帕罗西汀治疗早泄肝郁肾虚证的临床疗效.方法:将70例患者随机分为对照组(盐酸达泊西汀,35例)和治疗组(益肾疏肝止泻方加减联合帕罗西汀,35例),治疗4周后比较中医疗效、中医证候评分、阴道内射精潜伏期(IELT)、早泄简表(PEP)评分、射精控制力及个人痛苦改善情况,并记录不良反应与复发率.结果:治疗组总有效率88.57%,高于对照组的68.57%(P<0.05).治疗4周后,两组中医证候评分及总积分均显著降低(P<0.001),治疗组低于对照组(P<0.05).随访6个月,对照组各项评分较治疗后显著回升(P<0.05),治疗组无显著变化(P>0.05)且优于同期对照组(P<0.05).两组IELT及PEP各条目均较治疗前显著改善(P<0.001),治疗组在射精控制力、性交满意度、射精相关个人痛苦及人际交往困难方面的改善优于对照组(P<0.05).随访6个月,对照组IELT及PEP部分评分较治疗后显著下降(P<0.05),治疗组无统计学差异(P>0.05)且优于对照组(P<0.05).治疗后射精控制力、个人痛苦评分提升≥1分的比例治疗组优于对照组(P<0.05).两组均未见明显异常,不良反应发生率分别为14.29%、8.57%(P>0.05).治疗组复发率9.30%,低于对照组的37.50%(P<0.05).结论:益肾疏肝止泻方加减联合帕罗西汀治疗早泄肝郁肾虚证疗效显著,可有效缓解症状、延长IELT、提高射精控制力、改善性生活满意度,且安全性高、复发率低.
Objective:To explore the clinical efficacy of a modified Yishen Shugan Zhixie formula combined with paroxetine in treating premature ejaculation with liver depression and kidney deficiency syndrome.Methods:Seventy patients were randomly divided into a control group(dapoxetine hydrochloride,35 cases)and a treatment group(modified Yishen Shugan Zhixie formula combined with paroxetine,35 cases).After 4 weeks of treatment,the effica-cy of traditional Chinese medicine(TCM),TCM syndrome scores,intra vaginal ejaculation latency time(IELT),Pre-mature ejaculation profile(PEP)scores,ejaculatory control,and personal distress improvement were compared,along with adverse reactions and recurrence rates.Results:The total effective rate in the treatment group was 88.57%,higher than that in the control group(68.57%)(P<0.05).After 4 weeks of treatment,both groups showed significantly reduced TCM syndrome scores and total scores(P<0.001),with the treatment group lower than the control group(P<0.05).During a 6-month follow-up,the control group exhibited significant rebounds in all scores compared to post-treatment levels(P<0.05),while the treatment group showed no significant changes(P>0.05)and outper-formed the concurrent control group(P<0.05).Both groups demonstrated significant improvements in IELT and PEP items compared to pre-treatment levels(P<0.001),with the treatment group showing superior improvements in ejaculatory control,sexual satisfaction,ejaculatory-related personal distress,and interpersonal difficulties(P<0.05).During the 6-month follow-up,the control group exhibited significant declines in some IELT and PEP scores compared to post-treatment levels(P<0.05),while the treatment group showed no significant differences(P>0.05)and outperformed the control group(P<0.05).The proportion of patients achieving ≥1-point improve-ment in ejaculatory control and personal distress scores was higher in the treatment group than in the control group(P<0.05).No significant abnormalities were observed in either group,with adverse reaction rates of 14.29%and 8.57%(P>0.05),respectively.The recurrence rate in the treatment group was 9.30%,lower than that in the con-trol group(37.50%)(P<0.05).Conclusion:The modified Yishen Shugan Zhixie formula combined with paroxetine demonstrates significant efficacy in treating premature ejaculation with liver depression and kidney deficiency syn-drome,effectively alleviating symptoms,prolonging IELT,improving ejaculatory control,enhancing sexual satisfac-tion,and featuring high safety and low recurrence rates.
程易;陈乔;汤同娟;王天枢;戴宁
安徽中医药大学第一附属医院男科,安徽 合肥 230031安徽中医药大学第一附属医院男科,安徽 合肥 230031安徽中医药大学第一附属医院男科,安徽 合肥 230031安徽中医药大学第一附属医院男科,安徽 合肥 230031安徽中医药大学第一附属医院男科,安徽 合肥 230031
医药卫生
早泄肝郁肾虚证益肾疏肝止泻方达泊西汀帕罗西汀不良反应
Premature ejaculationLiver depression and kidney deficiency syndromeYishen Shugan Zhixie formulaDapoxetineParoxetineAdverse reaction
《陕西中医》 2026 (9)
1212-1217,6
安徽省高等学校科学研究项目(2022AH050464)安徽省名中医及基层名中医工作室建设项目(中发展[2020]10号)
评论